1 / 4

Global Blood Screening Market is Supposed to Reach US$ 3.00 Billion By 2021

The Blood Screening Market is expected to exceed more than US$ 2.80 Billion by 2021 at a CAGR of 9.7% in the given forecast period.

Télécharger la présentation

Global Blood Screening Market is Supposed to Reach US$ 3.00 Billion By 2021

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Global Blood Screening Market is Supposed to Reach US$ 3.00 Billion By2021 • Market Research Engine has published a new report titled as “Blood Screening Market By Technology Analysis (Nucleic Acid Test (NAT), Enzyme-linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assay, Next-generation Sequencing (NGS)); By End User Analysis (Blood Banks, Hospitals); By Product/Services Analysis (Reagents & Kits, Enzymes and Polymerases, Standards and Controls, Probes and Primers, Buffers, Nucleotides, and Solutions, Labeling and Detection Reagents, Immunosorbents, Controls, Conjugates, Substrates, Sample Diluents and Wash Solutions, Instruments, Software andServices)” • The Blood Screening Market is expected to exceed more than US$ 2.80 Billion by 2021 at a CAGR of 9.7% in the given forecastperiod. • Browse Full Report: https://www.marketresearchengine.com/blood-screening- market • Blood is a living tissue made up of fluid, with various cells and proteins suspended in it. It is a coursing liquid, containing red platelets, white platelets, and platelets. It gives oxygen and food to the body cells through vessels, conductors, and veins. It additionally expels metabolic waste and carbon dioxide from the body. A blood screening is a therapeutic procedure in which blood is analyzed for a particular illness or condition. It screens ailments and prevent medicinal issues and a combination of various conditions, for instance, maladies and danger. Blood screening is a medicinal procedure in which given blood is mostly tried for HIV1, HIV2, HBV, HCV, jungle fever, syphilis, and different irresistible ailments. Given blood is screened for these irresistible illnesses to lessen the danger of transfusion-transmitted contaminations (TTIs). The worldwide blood screening market comprises of different advances and items and administrations which are utilized as a part of blood donation centers and doctor's facilities for the screening of differentTTIs. • The major driving factors of Blood Screening Market are asfollows: • Growing demand for donated blood and thedonors. • Conducting number of blood donationcamps. • Increasing safety and knowledge of donatedblood. • Economic price and acceptance of NAT for bloodscreening. • The restraining factors of Blood Screening Market are asfollows: • Absence of proper regulations in developing countries for the use ofNAT. • High capital investments and high maintenance cost of NAT. • Evolution of substitute technologies.

  2. The Blood Screening Market is segmented on the lines of its product, service, technology, end user and regional. Based on product, services segmentation it coversreagents & kits, enzymes and polymerases, standards and controls, probes and primers, buffers, nucleotides, and solutions, labeling and detection reagents, immunosorbents, controls, conjugates, substrates, sample diluents and wash solutions, instruments, software and services. Based on technology segmentation it covers nucleic acid test (NAT), enzyme- linked immunosorbent assay (ELISA), rapid tests, western blot assay, next-generation sequencing (NGS). Based on end user segmentation it covers blood banks, hospitals.The Blood Screening Marketon geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCCcountries. • This reportprovides: • An overview of the global market for Blood Screening Market and relatedtechnologies. • Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through2021. • Identifications of new market opportunities and targeted promotional plans for Blood Screening Market. • Discussion of research and development, and the demand for new products and new applications. • Comprehensive company profiles of major players in theindustry. • REPORTSCOPE: • The scope of the report includes a detailed study of global and regional markets on Blood Screening Market with the reasons given for variations in the growth of the industry in certain regions. • The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Ortho Clinical Diagnostics, Inc. (U.S.), Becton, Grifols (Spain), Dickinson and Company (U.S.), Roche Diagnostics (Switzerland), Beckman Coulter, Inc. (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and Siemens Healthineers (Germany), and bioMérieux (France).Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and currentdevelopments. • Request Sample Report: https://www.marketresearchengine.com/blood-screening- market • The Blood Screening Markethas been segmented as below: (Accordingly) By Technology Analysis: • Nucleic Acid Test(NAT) • Transcription-mediated Amplification(TMA) • Real-time Polymerase Chain Reaction(PCR) • Enzyme-linked Immunosorbent Assay(ELISA)

  3. ByPlatform • Chemiluminescence Immunoassay(CLIA) • Fluorescence Immunoassay (FIA) • Colorimetric Immunoassay(CI) • ByGeneration • FirstGeneration • Second Generation • ThirdGeneration • Fourth Generation & Above • Rapid Tests • Western BlotAssay • Next-generation Sequencing(NGS) • By End User Analysis: • Blood Banks • Hospitals • By Product/ServicesAnalysis: • Reagents & Kits • o NAT Reagents &Kits • Enzymes andPolymerases • Standards andControls •  •  •  Probes andPrimers Buffers, Nucleotides, andSolutions Labeling and DetectionReagents • o ELISA Reagents &Kits • Immunosorbents • Controls • Conjugates • Substrates • Sample Diluents and WashSolutions • Other Reagents &Kits • Instruments • RentalPurchase • OutrightPurchase • Software andServices • By RegionalAnalysis • North America Europe • Asia-Pacific • Rest of theWorld

  4. AboutMarketResearchEngine.com Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop businessstrategies. MediaContact Company Name: Market ResearchEngine Contact Person: JohnBay Email:john@marketresearchengine.com Phone: +1-855-984-1862 Country: UnitedStates Website:https://www.marketresearchengine.com/

More Related